SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/β‐catenin pathway

Bladder cancer (BC) is a major disease of the genitourinary tract, and chemotherapy is one of the main treatments commonly used at present. SC66 is a new type of allosteric AKT inhibitor that is reported to play an effective inhibitory role in the progression of many other types of tumours, but ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wu, Zhao, Sheng, Yu, Weimin, Rao, Ting, Ruan, Yuan, Zhu, Shaoming, Xia, Yuqi, Song, Hongfei, Cheng, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581318/
https://www.ncbi.nlm.nih.gov/pubmed/34687144
http://dx.doi.org/10.1111/jcmm.17005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581318/
https://www.ncbi.nlm.nih.gov/pubmed/34687144
http://dx.doi.org/10.1111/jcmm.17005

Ejemplares similares